Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

How to get reimbursed for renal denervation
Herbert D. Aronow, MD, reviewed the many ways the reimbursement landscape is changing thanks to new Medicare policies. “This is a really exciting time in the renal denervation space," he said.
Hospitals providing organs to wealthy international patients, leaving Americans waiting
A new report from the New York Times reveals a system of de facto quid pro quo where wealthy patients from oil-rich nations are sometimes moved to the top of organ transplant lists.
Dynamic chest radiography could potentially replace pulmonary function tests
The X-ray technique uses continuous radiographic acquisition during respiration to assess lung function.
CMS considers Medicare coverage for TAVR in asymptomatic patients
After an official request from Edwards Lifesciences, CMS is rethinking its coverage policy for the use of TAVR to treat asymptomatic severe aortic stenosis. The agency is accepting public comments on this topic until Jan. 14.
Newest TAVR valve from Edwards Lifesciences improves survival, real-world data confirm
A fifth-generation TAVR valve from Edwards Lifesciences was associated with improved outcomes compared to the device's predecessors in a new real-world analysis out of Cedars Sinai.

Testing nursing homes for COVID-19 costs $440M

Testing all residents and staff at the nation’s nursing homes just once would collectively cost $440 million, according to data from the American Health Care Association and National Center of Assisted Living (AHCA/NCAL).

Cath labs join forces, reduce radiation dose across the board

Cardiac cath labs can achieve significant radiation dose reductions through focused, collaborative quality improvement (QI) efforts, according to a new analysis published in Circulation: Cardiovascular Interventions.

President Trump says he is taking hydroxychloroquine to prevent COVID-19 infection

The news came just weeks after the FDA warned against treating COVID-19 with hydroxychloroquine “outside of the hospital setting or a clinical trial” due to significant cardiovascular complications.

Association of Black Cardiologists shares COVID-19 resources for patients, providers

The Association of Black Cardiologists (ABC) has shared resources for patients and healthcare providers focused on COVID-19’s impact on black communities and other underserved patient populations.

Edwards valve repair system receives CE mark approval for tricuspid regurgitation

Edwards Lifesciences’ PASCAL transcatheter valve repair system has gained CE mark approval for treating tricuspid regurgitation (TR).

Civica Rx partners with US government to produce generics for COVID-19 response

Civica Rx has teamed up with the U.S. government to aid in the COVID-19 response.

What we know—and don’t know—about assessing nonculprit lesions after STEMI

How should nonculprit lesions be evaluated? And when is the ideal time for complete revascularization?

Cardiothoracic surgeons satisfied with their careers, but risk of burnout remains

Heart and lung surgeons are as satisfied with their jobs as ever, according to new survey results published in The Annals of Thoracic Surgery.

Clinical

How to get reimbursed for renal denervation

Hospitals providing organs to wealthy international patients, leaving Americans waiting

Dynamic chest radiography could potentially replace pulmonary function tests

CMS considers Medicare coverage for TAVR in asymptomatic patients

Newest TAVR valve from Edwards Lifesciences improves survival, real-world data confirm